Somaxon's Silenor Gains An FDA Approval, But Can The Pharma Afford A Launch?
This article was originally published in The Pink Sheet Daily
Executive Summary
Somaxon hopes to launch its insomnia drug in the second half of 2010, but is still searching for a U.S. commercial partner.